Relative Selectivity of Covalent Inhibitors Requires Assessment of Inactivation Kinetics and Cellular Occupancy: A Case Study of Ibrutinib and Acalabrutinib
Por um escritor misterioso
Descrição
Development of covalent inhibitors: Principle, design, and application in cancer - Zheng - 2023 - MedComm – Oncology - Wiley Online Library
B-cell receptor dependent phagocytosis and presentation of particulate antigen by chronic lymphocytic leukemia cells
Deciding between one-step and two-step irreversible inhibition mechanisms on the basis of “kobs” data: A statistical approach
Pharmaceuticals, Free Full-Text
Structural and biophysical insights into the mode of covalent binding of rationally designed potent BMX inhibitors - RSC Chemical Biology (RSC Publishing) DOI:10.1039/D0CB00033G
Covalent Modifiers: 2017
Kinetic mechanisms of covalent inhibition - ScienceDirect
Tyrosine Kinase: Most Up-to-Date Encyclopedia, News & Reviews
Covalent Modifiers: 2017
de
por adulto (o preço varia de acordo com o tamanho do grupo)
:max_bytes(150000):strip_icc()/multiple-sclerosis-symptoms-brain-stem-2440518_v2-184e9886faa9445da09ccfce787830ee.png)
